Spire Healthcare £1bn takeover clears FCA hurdle

Spire Healthcare has cleared a key regulatory hurdle on the way to a £1.03 billion takeover, leaving court approval as the final step before one of Britain's largest private hospital groups leaves the London stock market.
The company said on Friday that a condition set by the UK Financial Conduct Authority had been satisfied on Thursday, clearing the way for the planned acquisition by Tulip UK Bidco to proceed towards completion in December.
A £1.03 billion deal
Tulip UK Bidco is a newly formed company owned by funds managed or advised by Toscafund Asset Management, THCP Advisory and Ares Management. Its offer values Spire's equity at £1.03 billion.
The recommended cash offer was agreed in September and is being carried out through a court-approved scheme of arrangement, the route commonly used for agreed takeovers of listed British companies.
Spire runs a network of private hospitals across the UK and is one of the country's largest private healthcare providers. A takeover would take the group private after years as a listed company, with the buying consortium betting on long-term demand for private hospital care.
What happens next
The deal still needs the scheme to be sanctioned by the court at a hearing on 3 December. If that goes ahead as planned, the scheme is expected to become effective on 7 December.
Spire expects its shares to be suspended in London from 7 December, with the last day of trading on 4 December. The shares are then expected to be cancelled on 8 December, ending the company's time as a listed business.
Investors have had the timetable in front of them for weeks. The scheme document was published at the end of September, and the company has said the expected timetable remains unchanged unless it announces otherwise.
Shareholders have already backed it
The takeover cleared its biggest shareholder test at the end of October, when investors voted overwhelmingly in favour at both the court meeting and the general meeting held on 30 October.
At the court meeting, 87.84% of the shareholders who voted backed the scheme, representing 99.90% of the shares voted. At the general meeting, 99.92% of votes were cast in favour of the resolution to approve the deal.
That level of support was widely expected. Toscafund had long been a major shareholder in Spire, and the board had recommended the final cash offer to investors.
Shares edge higher
Spire shares were 0.7% higher at 249.25p on Friday afternoon in London as the market digested the regulatory news.
The modest move reflects how little uncertainty remains. With shareholders on board and the regulator's condition now satisfied, the court hearing is the last formal step before the deal completes and Spire's shares stop trading.
For patients and staff, the change of ownership is not expected to alter day-to-day operations at the group's hospitals in the short term. For the market, it is another large British company heading for the exit from the London Stock Exchange.